Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level-Reference-Cited by-同舟云学术

Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level

Published:2022-03-30 Issue:2 Volume:92 Page:164-172
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Langer‐Gould Annette¹^ORCID,Cheng Stephen C.²,Li Bonnie H.³,Smith Jessica B.³,Kanter Michael H.⁴,

Affiliation:

1. Los Angeles Medical Center, Department of Neurology Southern California Permanente Medical Group Los Angeles California

2. Kaiser Foundation Health Plan Drug Use Management Downey California

3. Department of Research and Evaluation Southern California Permanente Medical Group Pasadena California

4. Department of Clinical Science Bernard J. Tyson School of Medicine Pasadena California

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26352

Reference15 articles.

1. Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D

2. Institute for Clinical and Economic Review.Disease‐modifying therapies for relapsing‐remitting and primary progressive multiple sclerosis: effectiveness and value. Final evidence report. March 6 2017. Available at:http://icerorg.wpengine.com/wp-content/uploads/2020/10/CTAF_MS_Final_Report_030617.pdf. Accessed September 1 2020.

3. The Multiple Sclerosis Treatment Optimization Program

4. Improving quality, affordability, and equity of multiple sclerosis care

5. Institute for Clinical and Economic Review.Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value. Final evidence report. June 20 2019. Available at:https://34eyj51jerf417itp82ufdoe-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/ICER_MS_Final_Evidence_Report_062019.pdf. Accessed September 1 2020.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in Maternal and Infant Outcomes;Neurology;2024-02-27

2. Rituximab for Multiple Sclerosis;Neurology;2024-01-23

3. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint;The Lancet Regional Health - Europe;2023-06

4. Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice;Revue Neurologique;2023-04

5. Treatment Courses of Patients Newly Diagnosed with Multiple Sclerosis in 2012–2018;Journal of Clinical Medicine;2023-01-11